Rethinking Cytoreductive Nephrectomy in Metastatic RCC Rethinking Cytoreductive Nephrectomy in Metastatic RCC
Recent data suggest that cytoreductive nephrectomy may confer a significant survival advantage in metastatic renal cell carcinoma.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 24, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
' Alarming' Decrease in Survival as Surgery Underused in mRCC'Alarming' Decrease in Survival as Surgery Underused in mRCC
Cytoreductive nephrectomy in patients with metastatic renal cancer has been underutilized since the advent of targeted therapy, despite lack of hard evidence that survival is not adversely affected.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 19, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Study examines different types of surgery for kidney cancer
For completely endophytic kidney tumors, which grow inward, both open partial nephrectomy (OPN) and robotic partial nephrectomy (RPN) led to excellent patient outcomes in a recent study.08/02/2016 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 2, 2016 Category: Urology & Nephrology Source Type: news
Study examines different types of surgery for kidney cancer
(Wiley) For completely endophytic kidney tumors, which grow inward, both open partial nephrectomy (OPN) and robotic partial nephrectomy (RPN) led to excellent patient outcomes in a recent study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 1, 2016 Category: Global & Universal Source Type: news
Nephrectomy for RCC May Result in Significant Declines in Renal Function
Patients with RCC had greater postsurgical decreases in kidney function compared with patients with upper tract urothelial carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - July 28, 2016 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Genitourinary Cancers News Renal Cell Carcinoma Source Type: news
Study finds surgery can lengthen survival of metastatic kidney cancer patients
(Dana-Farber Cancer Institute) Researchers find cytoreductive nephrectomy may offer an overall survival benefit to patients with metastatic kidney cancer who are treated with targeted therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 20, 2016 Category: Cancer & Oncology Source Type: news
Patients Needed for Research Project
A major pharmaceutical manufacturer has commissioned market research to help improve its communications directed toward Renal Cell Carcinoma (RCC) patients.Your participation in this research project can help ensure that the company’s website and other materials are relevant to patients’ concerns and expressed in a clear and comprehensible way.Flince Research + Design, an independent healthcare research and consulting firm located in the U.S., has been engaged to conduct these research interviews on pharmaceutical manufacturer’s behalf. The research project&n...
Source: Kidney Cancer Association - March 15, 2016 Category: Urology & Nephrology Source Type: news
Patients Needed for Research Project
A major pharmaceutical manufacturer has commissioned market research to help improve its communications directed toward Renal Cell Carcinoma (RCC) patients.
Your participation in this research project can help ensure that the company’s website and other materials are relevant to patients’ concerns and expressed in a clear and comprehensible way.
Flince Research + Design, an independent healthcare research and consulting firm located in the U.S., has been engaged to conduct these research interviews on pharmaceutical manufacturer’s behalf. The research proje...
Source: Kidney Cancer Association - March 15, 2016 Category: Urology & Nephrology Source Type: news
H3K36me3 and Risk of Renal Cell Carcinoma-Specific DeathH3K36me3 and Risk of Renal Cell Carcinoma-Specific Death
This study suggests H3K36me3 expression may be useful as a prognostic biomarker post-nephrectomy for clear cell renal carcinoma. Modern Pathology (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 18, 2016 Category: Pathology Tags: Pathology & Lab Medicine Journal Article Source Type: news
Removal of complex renal tumors performed safely by robotic surgery in selected patients
(Elsevier Health Sciences) Renal cell carcinoma can sometimes spread to the inferior vena cava (IVC), the body's largest vein, posing a threat to the heart and brain. Robotic nephrectomy for inferior vena cava tumor thrombus has favorable outcomes in selected patients compared with open surgery, which can have a high rate of complications, report surgeons in The Journal of Urology®. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 7, 2016 Category: Cancer & Oncology Source Type: news
Titan Medical debuts Sport robot assisted surgery prototype
Titan Medical (CVE:TMD) yesterday introduced the prototype of its Sport robot-assisted surgery device to investors in New York as it gears up for 1st-in-human trials this year.
Titan is chasing TransEnterix (NYSE:TRXC) in the race to challenge robot-assisted surgery’s dominant player, Intuitive Surgical (NSDQ:ISRG), and its da Vinci system. TransEnterix’s SurgiBot is expected to hit the U.S. market during the 1st half of this year; Titan’s Sport offering is anticipated for mid-2017.
Late-comers to the space include the Verb joint venture between Johnson & Johnson (NYSE:JNJ) and Google (NSDQ:GOOG) ...
Source: Mass Device - January 21, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Robot-Assisted Surgery Wall Street Beat Intuitive Surgical Inc. Titan Medical Inc. Source Type: news
First of its kind robotic-assisted surgery makes cover of Urology
Physicians at Upstate Medical University highlight complex case involving nephrectomy, thrombectomy and lymph node removal with robotic assistance in Urology. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - January 19, 2016 Category: Universities & Medical Training Source Type: news
Tumor Burden Postsurgery Not Predictive of Survival in mRCCTumor Burden Postsurgery Not Predictive of Survival in mRCC
Using three-dimensional volumetric measurements, higher primary tumor burden was not associated with poor overall survival in patients with mRCC who underwent cytoreductive nephrectomy. Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 9, 2015 Category: Radiology Tags: Hematology-Oncology News Source Type: news
